Allen Easley Cato Insider Profile
4 Followers
Allen Easley Cato, Ten Percent Owner at VistaGen Therapeutics, holds 452.62K shares in VistaGen Therapeutics (Ticker: VTGN), holds 3.97M shares in Echo Therapeutics (Ticker: ECTE). Most recently, Allen Easley Cato Bought ― shares of VistaGen Therapeutics on Dec 16, 2011 for an estimated value of $113.62M.
Allen Easley Cato's Trading History
| VTGNVistaGen Therapeutics | Dec 16, 2011 | Ten Percent Owner | Informative Buy | 113.62M | $83.28K | |
| ECTEEcho Therapeutics | ― | ― | ― | $119.06K |
You May Also Like
Allen Easley Cato insider profile FAQ
What is the percentage of profitable transactions made by Allen Easley Cato?
The percentage of profitable transactions made by Allen Easley Cato is 0%.
What is the average return per transaction made by Allen Easley Cato?
The average return per transaction made by Allen Easley Cato is -77.30%.
What stocks does Allen Easley Cato hold?
Allen Easley Cato holds: VTGN, ECTE stocks.
What was Allen Easley Cato’s latest transaction?
Allen Easley Cato’s latest transaction was an Informative Buy of $113.62M.
What was Allen Easley Cato's most profitable transaction?
Allen Easley Cato’s most profitable transaction was an Informative Buy of VTGN stock on December 16, 2011. The return on the trade was -74.80%.
What is Allen Easley Cato's role in VistaGen Therapeutics?
Allen Easley Cato's role in VistaGen Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
